{"title": "\u00bfSon las vacunas frente al SARS-CoV-2 eficaces y seguras en los pacientes con enfermedad renal cr\u00f3nica? | Nefrolog\u00eda", "author": "Broseta; Jos\u00e9 Jes\u00fas; Rodr\u00edguez-Espinosa; Diana; Maduell; Francisco", "url": "http://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "hostname": "revistanefrologia.com", "description": null, "sitename": "Nefrolog\u00eda (English Edition)", "date": "2022-06-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Journal Information\n[NefroPlus. Vol. 14. Issue. 01.](/en-vol-14-num-01-sumario-X1888970022X00010)June 2022\nPages 1-98\nShare\n[](/en-pdf-X1888970022034270)\nDownload PDF\n[NefroPlus. Vol. 14. Issue. 01.](/en-vol-14-num-01-sumario-X1888970022X00010)June 2022\nPages 1-98\nFull text access\n\u00bfSon las vacunas frente al SARS-CoV-2 eficaces y seguras en los pacientes con enfermedad renal cr\u00f3nica?\nVisits\n1027\nThis item has received", "language": null, "image": "https://multimedia.elsevier.es/PublicationsMultimediaV1/revista/cover/20132514?idApp=UINPBA000064", "pagetype": "article", "links": ["/", "en-busqueda-avanzada", "/en-compartir-twitter?item=X1888970022034270", "/en-compartir-facebook?item=X1888970022034270", "/en-compartir-linkedin?item=X1888970022034270", "whatsapp://send?text=http://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "mailto:?subject=I%20would%20like%20to%20share%20with%20you%20%20%C2%BFSon%20las%20vacunas%20frente%20al%20SARS-CoV-2%20eficaces%20y%20seguras%20en%20los%20pacientes%20con%20enfermedad%20renal%20cr%C3%B3nica%3F&body=https://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "/en-guia-autores", "/en-compartir-twitter?item=X1888970022034270", "/en-compartir-facebook?item=X1888970022034270", "/en-compartir-linkedin?item=X1888970022034270", "whatsapp://send?text=http://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "mailto:?subject=I%20would%20like%20to%20share%20with%20you%20%20%C2%BFSon%20las%20vacunas%20frente%20al%20SARS-CoV-2%20eficaces%20y%20seguras%20en%20los%20pacientes%20con%20enfermedad%20renal%20cr%C3%B3nica%3F&body=https://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "en-busqueda-avanzada", "/en-vol-14-num-01-sumario-X1888970022X00010", "/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "/en", "/en-ahead-of-print", "/en-vol-43-num-3-sumario-S2013251423X00066", "/en-numeros-anteriores", "/en-suplementos", "https://nefrologiaaldia.org/", "/en-alerta-email", "/en-guia-autores", "/en-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/en-acerca-revista", "/en-comite-editorial", "https://www.senefro.org/modules.php?name=webstructure&idwebstructure=6", "mailto:revistanefrologia@elsevier.com", "/en-contratar", "/en-mas-leidos", "/en-metricas", "https://www.revistanefrologia.com/en-open-access", "https://multimedia.elsevier.es/PublicationsMultimediaV1/revista/cover/20132514?idApp=UINPBA000064", "https://twitter.com/SENefrologia", "/en-rss-ultimo", "/en-metricas#factorimpacto", "/en-metricas#citescore", "/en-metricas#sjr", "/en-metricas#snip", "/en-metricas", "/en-existe-relacion-entre-bloqueantes-del-articulo-X1888970022034260", "/en-el-descubrimiento-autoanticuerpos-dirigidos-nefrina-articulo-X1888970022034280", "/en-vol-14-num-01-sumario-X1888970022X00010", "/en-exportar-rif-X1888970022034270", "/en-compartir-twitter?item=X1888970022034270", "/en-compartir-facebook?item=X1888970022034270", "/en-compartir-linkedin?item=X1888970022034270", "whatsapp://send?text=http://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "mailto:?subject=I%20would%20like%20to%20share%20with%20you%20%20%C2%BFSon%20las%20vacunas%20frente%20al%20SARS-CoV-2%20eficaces%20y%20seguras%20en%20los%20pacientes%20con%20enfermedad%20renal%20cr%C3%B3nica%3F&body=https://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "javascript:imprimirItem()", "/en-pdf-X1888970022034270", "/es-epub-X1888970022034270", "/en-estadisticas-X1888970022034270", "/en-vol-14-num-01-sumario-X1888970022X00010", "/index.php?p=revista&tipo=pdf-simple&pii=X1888970022034270", "#13528", "#13528", "#13528", null, "/en-estadisticas-X1888970022034270", "/en-pdf-X1888970022034270", "/en-estadisticas-X1888970022034270", "/en-pdf-X1888970022034270", "/en-sars-cov-2-infection-on-kidney-transplant-avance-S2013251422000487?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/en-more-difficult-still-treating-severe-articulo-S2013251422000189?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/en-acute-kidney-injury-in-hospitalized-articulo-S2013251422000098?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/en-focal-segmental-glomerulosclerosis-associated-with-articulo-S2013251421001358?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/en-covid", "javascript:imprimirItem()", "mailto:?subject=I%20would%20like%20to%20share%20with%20you%20%20%C2%BFSon%20las%20vacunas%20frente%20al%20SARS-CoV-2%20eficaces%20y%20seguras%20en%20los%20pacientes%20con%20enfermedad%20renal%20cr%C3%B3nica%3F&body=https://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "/en-exportar-rif-X1888970022034270", "http://www.mendeley.com/import/?url=http://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "/en-estadisticas-X1888970022034270", "http://www.senefro.org", "/en-guia-autores", "/en-envio-manuscritos", "https://www.elsevier.com/editors/perk", "http://www.nefrologiaaldia.org/es", "https://www.friat.es/", "/en-ahead-of-print", "/", "/en-mas-leidos", "/en-numeros-anteriores", "http://www.nefrologialdia.org", "/en-guia-autores", "/en-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/en-comite-editorial", "/en-permisos-reproduccion", "https://www.elsevier.com/legal/elsevier-website-terms-and-conditions", "https://www.elsevier.com/legal/privacy-policy", "/en-contratar", "/en-alerta-email", "/en-rss-ultimo", "/en-contratar", "/en-contacto", "/en-comite-editorial", null, "/es", "/en", "/en", "/en-ahead-of-print", "/en-vol-43-num-3-sumario-S2013251423X00066", "/en-numeros-anteriores", "/en-suplementos", "https://nefrologiaaldia.org/", "/en-alerta-email", "/en-guia-autores", "/en-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/en-acerca-revista", "/en-comite-editorial", "https://www.senefro.org/modules.php?name=webstructure&idwebstructure=6", "mailto:revistanefrologia@elsevier.com", "/en-contratar", "/en-mas-leidos", "/en-metricas", "https://www.revistanefrologia.com/en-open-access", "/index.php?p=revista&tipo=pdf-simple&pii=X1888970022034270&r=498", "javascript:imprimirItem()", "mailto:?subject=I%20would%20like%20to%20share%20with%20you%20%20%C2%BFSon%20las%20vacunas%20frente%20al%20SARS-CoV-2%20eficaces%20y%20seguras%20en%20los%20pacientes%20con%20enfermedad%20renal%20cr%C3%B3nica%3F&body=https://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "/en-exportar-rif-X1888970022034270", "http://www.mendeley.com/import/?url=http://www.revistanefrologia.com/en-son-vacunas-frente-al-sars-cov-2-articulo-X1888970022034270", "/en-estadisticas-X1888970022034270"]}